GenNext provides services for protein and biopharmaceutical higher order structural analysis using its proprietary flash oxidation (FOX(tm)) technology. The firm's principals have identified several technical, safety, ease-of-use, and cost barriers that have limited adoption of Hydroxyl Radical Protein Footprinting (HRPF) in the biopharmaceutical industry to include use of dangerous, expensive lasers that demand substantial expertise and safety measures; the irreproducibility of HRPF caused by uncontrolled or unexpected background scavenging of OH radicals that complicates reproducibility and limits comparative studies and and the absence of intuitive, efficient, and easy-to-use data processing tools to streamline and facilitate HRPF data analysis. GenNext's FOX HRPF platform replaces costly, difficult, and dangerous lasers while also improving HRFP reproducibility and streamlining data analysis. The firm's platform also includes simple, safe, and integrated components along with data analysis software to accelerate the conduct of HRPF research.
